Literature DB >> 28431926

Multiple repair pathways mediate cellular tolerance to resveratrol-induced DNA damage.

Ying Liu1, Xiaohua Wu2, Xiaoqing Hu1, Ziyuan Chen1, Hao Liu1, Shunichi Takeda3, Yong Qing4.   

Abstract

Resveratrol (RSV) has been reported to exert health benefits for the prevention and treatment of many diseases, including cancer. The anticancer mechanisms of RSV seem to be complex and may be associated with genotoxic potential. To better understand the genotoxic mechanisms, we used wild-type (WT) and a panel of isogenic DNA-repair deficient DT40 cell lines to identify the DNA damage effects and molecular mechanisms of cellular tolerance to RSV. Our results showed that RSV induced significant formation of γ-H2AX foci and chromosome aberrations (CAs) in WT cells, suggesting direct DNA damage effects. Comparing the survival of WT with isogenic DNA-repair deficient DT40 cell lines demonstrated that single strand break repair (SSBR) deficient cell lines of Parp1-/-, base excision repair (BER) deficient cell lines of Polβ-/-, homologous recombination (HR) mutants of Brca1-/- and Brca2-/- and translesion DNA synthesis (TLS) mutants of Rev3-/- and Rad18-/- were more sensitive to RSV. The sensitivities of cells were associated with enhanced DNA damage comparing the accumulation of γ-H2AX foci and number of CAs of isogenic DNA-repair deficient DT40 cell lines with WT cells. These results clearly demonstrated that RSV-induced DNA damage in DT40 cells, and multiple repair pathways including BER, SSBR, HR and TLS, play critical roles in response to RSV- induced genotoxicity.
Copyright © 2017. Published by Elsevier Ltd.

Entities:  

Keywords:  DNA damage; DNA repair; DT40; Genotoxicity; Resveratrol

Mesh:

Substances:

Year:  2017        PMID: 28431926     DOI: 10.1016/j.tiv.2017.04.017

Source DB:  PubMed          Journal:  Toxicol In Vitro        ISSN: 0887-2333            Impact factor:   3.500


  1 in total

1.  Critical roles of Rad54 in tolerance to apigenin-induced Top1-mediated DNA damage.

Authors:  Zilu Zhao; Xiaohua Wu; Fang He; Cuifang Xiang; Xiaoyu Feng; Xin Bai; Xin Liu; Jingxia Zhao; Shunichi Takeda; Yong Qing
Journal:  Exp Ther Med       Date:  2021-03-18       Impact factor: 2.447

  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.